1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Legislation

House Extends Telehealth Benefits In Massive Spending Bill, Sends To Senate

 
• By Brian Bossetta

The US House has extended to Medicare recipients temporary waivers for telehealth coverage that was put in place at the onset of the COVID-19 pandemic. The legislation now moves to the Senate where it’s also expected to pass.

Telehealth Visit Xray
• Source: Alamy

As the COVID-19 pandemic postponed non-emergency hospital visits, many Americans turned to telehealth for the first time as the frequency of virtual visits skyrocketed.

In response, Congress lifted restrictions on telehealth coverage for Medicare beneficiaries until the end of the public health emergency (PHE), which was declared in March 2020

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Policy & Regulation

California Medtech Firms Resolve Patent Dispute Over Delivery Catheters

 
• By Brian Bossetta

Route 92 says it has reached a settlement with Q’Apel Medical over patent claims concerning its Tenzing delivery catheters.

Does Makary’s Reorg Choice Mark FDA Turning Point?

 
• By Michael McCaughan

US FDA Commissioner Martin Makary’s disavowal of a proposed reorganization plan may be an important turning point in the Trump Administration. The move does not improve the situation, but may mean the administration stops actively making things worse.

MedTech Europe’s Bisazza Urges Action As US Tariffs Jeopardize Critical Global Supply Chains

 
• By Amanda Maxwell

The intricate assembly of medical devices, often involving over 1,000 globally sourced components, faces severe disruption due to new US tariffs. These barriers could halt production and devastate small and medium-sized enterprises (SMEs), MedTech Europe’s CEO, Oliver Bisazza, warns in an interview with Medtech Insight.